Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2002
10/10/2002US20020146760 G protein-coupled receptor for use in treatment of alzheimer's disease
10/10/2002US20020146755 Compositions for use diagnostic tools in human threapeuti cs
10/10/2002US20020146754 Chromatographic apparatus for use in the detetion of preferentialparticles in sample
10/10/2002US20020146752 Classification and detection of bacillus; obtain sample, incubate with antibody, detect antigen antibody reaction, bound complex indicates bacillis present
10/10/2002US20020146749 Diagnosis and treatment of neuroectodermal tumors
10/10/2002US20020146748 Immunological detection of neosporosis using a recombinant antigen
10/10/2002US20020146747 TRAC1: modulators of lymphocyte activation
10/10/2002US20020146746 Methods of detecting specific cell lysis
10/10/2002US20020146745 Detecting preferntial particles in sample; obtain sample inc ubate with probes, expose to solid support, detect particles bound to binding complex
10/10/2002US20020146743 Stable isotope, site-specific mass tagging for protein identification
10/10/2002US20020146741 Processes for receptpor screening
10/10/2002US20020146740 Monitoring ligand binding to membrane proteins; obtain sample containing membrane proteins, incubate with ligands, detect binding of ligands
10/10/2002US20020146733 Linear and circular expression elements
10/10/2002US20020146730 Hydrogel-based microarray signal amplification methods and devices therefor
10/10/2002US20020146727 Compositions and methods for the therapy and diagnosis of breast cancer
10/10/2002US20020146724 Biopolymer sequence comparison
10/10/2002US20020146717 Probes for use as tool in detection of Cryptosporidium
10/10/2002US20020146716 Electrochemical sensor using intercalative, redox-active moieties
10/10/2002US20020146715 Spotting probe preferentially bound to solid support; obtain liquid containing probe, apply to surface of solid support, allow stain to form on solid support
10/10/2002US20020146710 Detecting preferental polypeptide in sample; obtain cells, transform with vector, recover transformed cells, monitor and evaluate gene expression in transformed cells
10/10/2002US20020146709 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/10/2002US20020146708 Diagnosing cancer in humans; obtain sample, detect expression of chymotrypsin, presence of chymotrypsin enzyme indicates cancer
10/10/2002US20020146706 Methods for classifying nucleic acids and polypeptides
10/10/2002US20020146704 Reagent for use in the analysis and determination of nucleotide sequences
10/10/2002US20020146703 Detecting preferential activity in sample; obtain reaction mixture, incubate with fluorescent particle, monitor flourescent polarization
10/10/2002US20020146702 Nucleic acid molecule associated with prostate cancer and melanoma immunodetection and immunotherapy
10/10/2002US20020146701 Protein complex for monitoring protein associations in sample
10/10/2002US20020146700 Diagnostics and therapeutics for diseases associated with an IL-1 inflammatory haplotype
10/10/2002US20020146695 Method for detection of the presence or absence of methylthioadenosine phosphorylase (MTAse) in a cell sample by detection of the presence or absence of MTAse encoding nucleic acid in the cell sample
10/10/2002US20020146694 Functionating genomes with cross-species coregulation
10/10/2002US20020146691 Detecting gene asociated with preferential phenotype; obtain preferential nucleotide sequences, transduce cells, culture cells, recover cell of preferential phenotype, monitor gene expression in recovered cells
10/10/2002US20020146687 Detecting cancer in humans; obtain cells, incubate with cadherins, monitor binding
10/10/2002US20020146686 Detecting nucleotide sequences asociated with preferential viral disease; obtain nuclotide sequence sample, incubate with probes, detect signal, presence of signal indicates viral nucleotide sequences
10/10/2002US20020146685 Kit for use in the accurate detection of viral infections
10/10/2002US20020146684 Generating preferential compounds; obtain protection compounds, incubate with chemical intermediates, remove terminal buliding blocks, recover compound
10/10/2002US20020146681 Determining cell cholesterol efflux of serum or isolated lipoprotein; obtain cell sample, incubate with scavenger, expose to binding proteins, measure concentration of cholesterol protein
10/10/2002US20020146680 Appararatus for use in the evaluation of cell prolifereative patterns
10/10/2002US20020146679 Method for creating endothelial cell dysfunction in cell culture
10/10/2002US20020146678 Determining preferential gene expression pattern in embryonic cells; obtain cells, monitor gene expresion products, incubate with animal growth regulators, monitor gene expresion pattern and differentiation in cells
10/10/2002US20020146677 Method and device for collecting and stabilizing a biological sample
10/10/2002US20020146630 Non-oxidizable bilirubin substitutes and uses therefor
10/10/2002US20020146504 Ternary biomolecule/polymer/surface-based immobilization systems
10/10/2002US20020146428 Preventing, inhibiting or enhancing binding between pilus subunit and periplasmic molecular chaperone in pilus-forming bacteria, periplasmic molecular chaperone being one that binds pilus subunits during transport of subunits
10/10/2002US20020146423 Protective helicobacter antigens
10/10/2002US20020146421 Diagnosis and treatment of malignant neoplasms
10/10/2002US20020146416 Human trk receptors and neurotrophic factor inhibitors
10/10/2002US20020146410 Monoclonal antibodies and their use
10/10/2002US20020146391 For diagnosis and therapy of susceptibility to atopic allergy, asthma
10/10/2002US20020146368 For determining the presence and/or concentration of biological and/or chemical substances in body; diagnosis
10/10/2002US20020146346 "One-device" system for testing constituents in fluids
10/10/2002US20020145960 Optical discs for measuring analytes
10/10/2002US20020145530 Conductor detecting device
10/10/2002US20020145006 Pepper agent system
10/10/2002US20020144905 Sample positioning and analysis system
10/10/2002US20020144800 Cold cranking simulator having hybrid heat transfer system
10/10/2002US20020144541 Small drill-hole, gas mini-permeameter probe
10/10/2002US20020144537 Air quality monitoring systems and methods
10/10/2002US20020144536 Method and apparatus for measuring the amount of entrained gases in a liquid sample
10/10/2002DE10152098A1 Vorrichtung zur Erzeugung ultrareinen Wassers A device for generating ultra-pure water
10/10/2002DE10143106C1 Amplifying RNA, useful e.g. for analysis on a microarray, comprises conversion to double-stranded cDNA, strand separation and transcription
10/10/2002DE10139637C1 Exploration of ore deposits involves forming thin sections from magnesium-iron silicate samples, analyzing sections using ion probe for main and trace elements, and evaluating analysis data obtained
10/10/2002DE10121033C1 Device used for measuring the carbon dioxide content in several greenhouses has a pump which continuously releases gas into measuring line arranged at each measuring point
10/10/2002DE10117698A1 Sensor system is for inspection of moving textile fibre material
10/10/2002DE10117381A1 Herstellung polyklonaler, monospezifischer Antikörper gegen die uPAR-Varianten del4, del5 und del4+5 sowie deren Verwendung für diagnostische und therapeutische Zwecke Production of polyclonal, monospecific antibodies to uPAR variants del4, del5 and del4 + 5 and their use for diagnostic and therapeutic purposes
10/10/2002DE10116552A1 Verfahren zur Bestimmung der wirksamen Parathormon-Aktivität in einer Probe A method for determining the effective parathyroid hormone activity in a sample
10/10/2002DE10115219A1 Verfahren und Vorrichtung zur Beurteilung der Funktionsfähigkeit einer Einrichtung zur Reduzierung des Ozongehaltes von Luft Method and device for assessing the operability of a device for reducing the ozone content of air
10/10/2002DE10115083A1 Nachweis von Milchdrüsenentzündungen Detection of mammary gland inflammation
10/10/2002DE10115073A1 Verwendung von Inhibitoren von IKK-ß und Verfahren zum Auffinden solcher Inhibitoren Use of inhibitors of IKK-ß and methods for finding such inhibitors
10/10/2002DE10110511C1 Verfahren zur Herstellung eines Arrays zur Detektion von Komponenten aus einer biologischen Probe A method of producing an array for the detection of components from a biological sample
10/10/2002CA2455915A1 Methods and compositions for using mhc class ii invariant chain polypeptide as a receptor for macrophage migration inhibitory factor
10/10/2002CA2443355A1 Central nervous system neural progenitor cell which induces synapse-forming neurons in the spinal cord
10/10/2002CA2443170A1 Diagnostic detection of nucleic acids
10/10/2002CA2443144A1 In vivo methods of determining activity of receptor-type kinase inhibitors
10/10/2002CA2443138A1 Anti-muc-1 single chain antibodies for tumor targeting
10/10/2002CA2443050A1 Immunomodulation and effect on cell processes relating to serotonin family receptors
10/10/2002CA2442944A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/10/2002CA2442879A1 Detection of abnormal cells
10/10/2002CA2442866A1 Detection and amplification of ligands
10/10/2002CA2442862A1 High-fidelity dna sequencing using solid phase capturable dideoxynucleotides and mass spectrometry
10/10/2002CA2442847A1 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
10/10/2002CA2442829A1 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
10/10/2002CA2442775A1 New polynucleotides and polypeptides of the ifn alpha-21 gene
10/10/2002CA2442718A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/10/2002CA2442674A1 Phosphoprotein target for insulin and its antagonists
10/10/2002CA2442654A1 Probes, systems, and methods for drug discovery
10/10/2002CA2442619A1 Cancer-testis antigens
10/10/2002CA2442363A1 Reducing the immunogenicity of fusion proteins
10/10/2002CA2442169A1 Nucleic acid analysis using non-templated nucleotide addition
10/10/2002CA2442074A1 Methods of detecting early renal disease in animals
10/10/2002CA2442064A1 G-protein coupled receptors
10/10/2002CA2442062A1 Secreted proteins
10/10/2002CA2442020A1 Methods of delivery of exogenous proteins to the cytosol and uses thereof
10/10/2002CA2441654A1 Cytoskeleton-associated proteins
10/10/2002CA2441382A1 A hepatitis b virus surface antigen mutant and methods of detection thereof
10/10/2002CA2440425A1 Holding device, particularly for body fluids, comprising a separating device, and a separating device therefor
10/10/2002CA2440108A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/10/2002CA2438391A1 Method for correlating gene expression profiles with protein expression profiles
10/10/2002CA2438030A1 Methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulators
10/10/2002CA2433910A1 Antibiotics from bacteria isolated from amphibian skin
10/10/2002CA2410812A1 Integrated sample testing meter
1 ... 2734 2735 2736 2737 2738 2739 2740 2741 2742 2743 2744 2745 2746 2747 2748 2749 2750 2751 2752 2753 2754 ... 3937